AMGN Buy Stats
On December 16, 1998, the Rule Breaker portfolio bought 290 shares of rule-breaking, biotech-leading Amgen Corp. (Nasdaq: AMGN). The price paid was $85 3/4 per share before commissions. For the buy report on Amgen which explains the company in detail and why it was bought, please click here.
More from The Motley Fool
Solar Companies Are Set Up for a Strong Earnings Season
Rising demand and prices for solar panel prices bode well for manufacturers.
Today's Workers Aren't Optimistic About Raises and Promotions, Data Shows
Surprisingly, a large number of workers across the globe think their chances of a pay or title boost are pretty low. Here's how to bust out of that cycle and propel your career forward.
Could These High-Flying Tech Stocks Start Paying a Dividend?
Alphabet, Facebook, and Adobe don't do it yet, but that could change sooner than you think.